Herceptin wins FDA approval for stomach cancer; EU to review patent settlements;

 @FiercePharma: FDA to rewarn docs on Plavix, Prilosec combo. Article | Follow @FiercePharma

> Roche got the FDA nod to market its drug Herceptin as a first-line treatment for patients with advanced stomach cancer. Roche release |  Report

> Actelion has announced an 800 million Swiss franc ($829 million) share buyback and reiterated its desire to stay independent, knocking hopes the Swiss biotech group could be sold and sending its shares lower. Report

> E.U. antitrust regulators plan to review drug patent settlements struck this year to delay cheaper generics, as part of their crackdown on illegal deals, a senior European Commission official said. Report

> Genzyme says its leukemia drug Clolar failed to meet its key treatment goal in a late-stage study of the drug as a potential treatment for acute myeloid leukemia. Report

> Two more patients taking Biogen Idec's multiple sclerosis drug Tysabri have developed a potentially deadly brain infection known as PML, the company says. Report

> Sihuan Pharmaceutical, China's largest cardio-cerebral vascular drugmaker, raised $741 million after its IPO sold at the top of its indicated range, a source with direct knowledge of the deal said. Report

> Japan's Nichi-Iko Pharmaceutical plans to acquire 33.4 percent of South Korea's Aprogen through a private placement. Report

Biotech News

 @FierceBiotech: Amylin shares crater after FDA rejects Bydureon app. News | Follow @FierceBiotech

 @JohnCFierce: I used to think the FDA was just getting a bit tougher. Now I wonder if it's becoming excessively cautious. Anyone have thoughts on that? Follow @JohnCFierce

> Cardiome shares plunge after FDA red lights vernakalant Ph3. Report

> In fresh setback, Lilly scuttles Ph3 teplizumab program. Article 

> Novartis biosimilars point to a blockbuster future. Item 

> Zealand Pharma tests chilly IPO waters. News 

Vaccines News

> A flu vaccine made using dog kidney cells appears to be as safe and effective as one produced using chicken eggs--the traditional, albeit slower method, according to a study. Report

> Charity bankrolls brain cancer vaccine trial. News

> MannKind starts Phase II melanoma vax trial. Article 

> Duke researchers to test mosaic HIV vax candidate. Item

> Australia accused of wasting millions on swine flu vax. Story

Manufacturing News

> J&J: Another recall, another earnings rise. Report

> Union leads worker blockade of Sanofi plant. Story 

> "Inadequates" in Gilead response led to FDA warning. Article 

> Newly posted warnings cite repeat violations. News 

> Nigeria is test-bed for online vs. offline fakes detection. Story 

> Pfizer buys seat at biosimilars table next to Biocon. Article

And Finally... The first European company to produce a drug from a genetically modified animal will soon begin distributing its treatment to patients. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.